<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-07-08T08:44:08Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/3CBDF851-17BD-4832-A83E-A6FCA2C51679" ns1:id="3CBDF851-17BD-4832-A83E-A6FCA2C51679"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/persons/FBD0FE5A-CEE3-475A-A617-C6A29B13E961" ns1:rel="PM_PER"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/75AF96FC-79E1-4E6A-B3A4-CB18D145C51C" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/DA331D93-6539-4A58-8165-1FEB062AE22C" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/6B57D64D-182B-4847-8A8F-366E0669D013" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/65E5C532-6163-4685-B656-A7C47CDB917E" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/75AF96FC-79E1-4E6A-B3A4-CB18D145C51C" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/DDAAB4D7-3322-4694-8758-8F06E1509D53" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2020-02-29T00:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/9727A6C8-7D73-41B7-A126-D80798EB5A85" ns1:rel="FUND" ns1:start="2016-03-01T00:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">102539</ns2:identifier></ns2:identifiers><ns2:title>Smart Responsive Antimicrobial Implants</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>Collaborative R&amp;D</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>The primary objective of this collaborative research project is to develop a smart antimicrobial orthopaedic implant suitable for mass production in the established and emerging markets. The 3yr project is industry led by a global medical device company (Smith and Nephew) collaborating with a charitable NHS hospital trust and
academia. The antimicrobial technology developed herein will help reduce the global threat of anti-microbial resistance and level of bioburden experienced in trauma by improving the aseptic conditions during surgery. The primary output of this project will be a demonstrator suitable for first in man/clinical trials, and a platform technology, which is applicable in other healthcare and industrial sectors given its high level of innovation..</ns2:abstractText></ns2:project>